Diebold Nixdorf (DBD) Misses Q3 EPS by 367c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q3 EPS of ($2.86), $3.67 worse than the analyst estimate of $0.81. Revenue for the quarter came in at $943.3 million versus the consensus estimate of $956.6 million.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- HSBC Raises S&P500 Target to 8,100
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
